Topotecan Kabi 4 mg powder for concentrate for solution for infusion
Country: Bulgarija
Lingwa: Bulgaru
Sors: Изпълнителна агенция по лекарствата
Fuljett ta 'informazzjoni
(PIL)
17-07-2013
Karatteristiċi tal-prodott
(SPC)
17-07-2013
Ingredjent attiv:
Топотекан
Disponibbli minn:
Fresenius Kabi Oncology PLc
Kodiċi ATC:
L01XX17
INN (Isem Internazzjonali):
Topotecan
Dożaġġ:
4 mg powder for concentrate for solution for infusion
Sommarju tal-prodott:
Topotecan Kabi, 4 mg powder for concentrate for solution for infusion x 1; x 5;
Data ta 'l-awtorizzazzjoni:
2013-11-06
